Annual EBITDA
-$261.52M$102.47M-64.43%
Summary
- Current Value
- As of today, PHAT annual EBITDA is -$261.52M, down -64.43% on
- Historical Performance
- PHAT annual EBITDA is down -91.49% over the past 3 years, and down -4.21% over the past 5 years
- All-Time High Comparison
- PHAT annual EBITDA is currently -20411.53% below its historical high of -$1.28M set on
- 3-Year Low Comparison
- PHAT annual EBITDA is at its 3-year low
- Sector Comparison
- PHAT annual EBITDA is higher than 5.26% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$261.52M | -64.4% | -91.5% | -4.2% | -10000.0% | |
| Quarterly EBITDA | -$15.12M | +78.6% | +64.3% | +53.8% | -5539.9% | |
| TTM EBITDA | -$212.78M | +25.9% | -34.5% | -139.9% | -10000.0% | |
| Price | $18.08 | +151.1% | +140.4% | -50.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $55.25M | +8001.5% | +100.0% | +100.0% | +100.0% | |
| Annual EPS | -$5.29 | -34.6% | -36.1% | +48.7% | -9980.0% | |
| -$262.32M | -64.3% | -91.3% | -4.5% | -10000.0% | ||
| Annual Net Income | -$334.33M | -65.8% | -132.4% | -31.0% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$159.05M | -64.4% | |
| 5Y | -$124.16M | N/A | -110.6% |
| All | -$1.28M | >-9999.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$261.52M | at low | |
| 5Y | -$261.52M | at low | |
| All | -$261.52M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$261.52M | -64.4% | |
| -$159.05M | +6.3% | |
| -$169.80M | -24.3% | |
| -$136.57M | -10.0% |
| Year | Value | Change |
|---|---|---|
| -$124.16M | +50.5% | |
| -$250.95M | >-9,900.0% | |
| -$1.28M | - |
FAQ
What is the current annual EBITDA of PHAT?
As of today, PHAT annual EBITDA is -$261.52M
What is 1-year change in PHAT annual EBITDA?
PHAT annual EBITDA is down -64.43% year-over-year
What is 3-year change in PHAT annual EBITDA?
PHAT annual EBITDA is down -91.49% over the past 3 years
How far is PHAT annual EBITDA from its all-time high?
PHAT annual EBITDA is currently -20411.53% below its historical high of -$1.28M set on December 31, 2018
How does PHAT annual EBITDA rank versus sector peers?
PHAT annual EBITDA is higher than 5.26% of companies in Healthcare sector
When is PHAT next annual earnings release?
The next annual earnings release for PHAT is on
Quarterly EBITDA
-$15.12M$44.64M+74.70%
Summary
- Current Value
- As of today, PHAT quarterly EBITDA is -$15.12M, up +74.70% on
- Historical Performance
- PHAT quarterly EBITDA is up +78.59% year-over-year, and up +64.31% over the past 3 years
- All-Time High Comparison
- PHAT quarterly EBITDA is currently -5539.93% below its historical high of -$268.00K set on
- 3-Year Low Comparison
- PHAT quarterly EBITDA is +80.79% above its 3-year low of -$78.69M reached on
- Sector Comparison
- PHAT quarterly EBITDA is higher than 25.38% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$15.12M | +74.7% | +78.6% | +64.3% | +53.8% | |
| Annual EBITDA | -$261.52M | – | -64.4% | -91.5% | -4.2% | |
| TTM EBITDA | -$212.78M | +20.7% | +25.9% | -34.5% | -139.9% | |
| Price | $18.08 | +66.8% | +151.1% | +140.4% | -50.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $49.50M | +25.3% | +202.7% | +100.0% | +100.0% | |
| Quarterly EPS | -$0.41 | +61.0% | +69.2% | +69.0% | +60.0% | |
| -$15.27M | +74.5% | +78.4% | +64.1% | +53.5% | ||
| Quarterly Net Income | -$29.97M | +60.5% | +65.0% | +41.3% | +12.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$15.12M | at high | |
| 3Y | -$15.12M | at high | |
| 5Y | -$15.12M | at high | |
| All | -$268.00K | -5539.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$78.69M | +80.8% | |
| 3Y | -$78.69M | +80.8% | |
| 5Y | -$78.69M | +80.8% | |
| All | -$78.69M | +80.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of PHAT?
As of today, PHAT quarterly EBITDA is -$15.12M
What is PHAT quarterly EBITDA most recent change?
PHAT quarterly EBITDA was up +74.70% on September 30, 2025
What is 1-year change in PHAT quarterly EBITDA?
PHAT quarterly EBITDA is up +78.59% year-over-year
How far is PHAT quarterly EBITDA from its all-time high?
PHAT quarterly EBITDA is currently -5539.93% below its historical high of -$268.00K set on September 30, 2018
How does PHAT quarterly EBITDA rank versus sector peers?
PHAT quarterly EBITDA is higher than 25.38% of companies in Healthcare sector
When is PHAT next earnings release?
The next earnings release for PHAT is on
TTM EBITDA
-$212.78M$55.49M+20.68%
Summary
- Current Value
- As of today, PHAT TTM EBITDA is -$212.78M, up +20.68% on
- Historical Performance
- PHAT TTM EBITDA is up +25.90% year-over-year, and down -34.46% over the past 3 years
- All-Time High Comparison
- PHAT TTM EBITDA is currently -79294.40% below its historical high of -$268.00K set on
- 3-Year Low Comparison
- PHAT TTM EBITDA is +25.90% above its 3-year low of -$287.14M reached on
- Sector Comparison
- PHAT TTM EBITDA is higher than 6.50% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$212.78M | +20.7% | +25.9% | -34.5% | -139.9% | |
| Annual EBITDA | -$261.52M | – | -64.4% | -91.5% | -4.2% | |
| Quarterly EBITDA | -$15.12M | +74.7% | +78.6% | +64.3% | +53.8% | |
| Price | $18.08 | +66.8% | +151.1% | +140.4% | -50.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $147.19M | +29.1% | +460.3% | +100.0% | +100.0% | |
| TTM EPS | -$3.81 | +19.4% | +33.0% | +18.3% | +39.0% | |
| -$213.48M | +20.6% | +25.9% | -34.4% | -140.1% | ||
| TTM Net Income | -$274.55M | +16.8% | +19.1% | -53.8% | -58.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$212.78M | at high | |
| 3Y | -$143.52M | -48.3% | |
| 5Y | -$125.37M | N/A | -69.7% |
| All | -$268.00K | >-9999.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$285.62M | +25.5% | |
| 3Y | -$287.14M | +25.9% | |
| 5Y | -$287.14M | +25.9% | |
| All | -$287.14M | +25.9% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of PHAT?
As of today, PHAT TTM EBITDA is -$212.78M
What is PHAT TTM EBITDA most recent change?
PHAT TTM EBITDA was up +20.68% on September 30, 2025
What is 1-year change in PHAT TTM EBITDA?
PHAT TTM EBITDA is up +25.90% year-over-year
How far is PHAT TTM EBITDA from its all-time high?
PHAT TTM EBITDA is currently -79294.40% below its historical high of -$268.00K set on September 30, 2018
How does PHAT TTM EBITDA rank versus sector peers?
PHAT TTM EBITDA is higher than 6.50% of companies in Healthcare sector
When is PHAT next earnings release?
The next earnings release for PHAT is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- PHAT Official Website www.phathompharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1783183/000119312525257390/0001193125-25-257390-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1783183/000095017025034183/0000950170-25-034183-index.htm
- PHAT Profile on Yahoo Finance finance.yahoo.com/quote/PHAT
- PHAT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/phat